Zanamivir
In the US, Zanamivir (zanamivir systemic) is a member of the following drug classes: inhaled anti-infectives, neuraminidase inhibitors and is used to treat Influenza, Influenza Prophylaxis and Swine Flu.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J05AH01
CAS registry number (Chemical Abstracts Service)
0139110-80-8
Chemical Formula
C12-H20-N4-O7
Molecular Weight
332
Therapeutic Categories
Antiviral agent
Neuraminidase inhibitor
Treatment of influenza
Chemical Name
D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminoethyl)amino]-2,6-anhydro-3,4,5-trideoxy-
Foreign Names
- Zanamivirum (Latin)
- Zanamivir (German)
- Zanamivir (French)
- Zanamivir (Spanish)
Generic Names
- Zanamivir (OS: BAN, USAN, DCF)
- GG 167 (IS: GlaxoWellcome)
- GR 121167 X (IS: GlaxoWellcome)
Brand Names
- Relenza
GlaxoSmithKline, Germany; Glaxo Wellcome, Portugal; Glaxo Wellcome, Serbia; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Estonia; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Georgia; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Poland; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Tunisia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States; GlaxoSmithKline, South Africa - Zanamivir - Simcere Pharm
Simcere, China
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
